newsroom:
Drug overdoses surged during the pandemic. Providers are thinking outside the box to combat the opioid crisis
Tabula Rasa’s, Robert L. Alesiani, PharmD, BCGP, Chief Pharmacist and Chief Pharmacotherapy Officer is quoted in Fierce Healthcare. Alesiani discusses how MedWise® was created to monitor patients for adverse drug reactions (ADEs) and take into account patients’ genomic background to determine whether their body produces particular metabolic enzymes.
newsroom:
What to Know About Anxiety Medications
Tabula Rasa HealthCare’s Robert L. Alesiani, PharmD, BCGP, Chief Pharmacist and Chief Pharmacotherapy Officer speaks on anxiety disorders and how they affect millions of people in the U.S. As a healthcare technology company that aims to decrease adverse medication-related events, he discusses when anxiety needs to be addressed.
newsroom:
TRHC to Exhibit and Present at APhA Annual Meeting and Exposition
MOORESTOWN, N.J., March 16, 2018 – Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC) a healthcare technology company optimizing medication safety by deploying new medication risk identification and mitigation software solutions and novel, proprietary medication decision support tools, will be participating full-force at the 2018 American Pharmacists Association [...]
newsroom:
TRHC’s CareKinesis Achieves Board Certified Geriatric Pharmacist Recognition Across All Clinicians
Aging populations to benefit from unmatched expertise in drug safety and effectiveness
Moorestown, NJ, September 11, 2017–Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that an unprecedented 100% of its eligible clinicians within subsidiary CareKinesis, have achieved [...]